former novartis exec to lead cambridge diabetes startup semma.. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..
.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..
by continuing to use this site you consent to the use of cookies on your device as described in our.